Breaking News Instant updates and real-time market news.

GH

Guardant Health

$76.00

-4.86 (-6.01%)

11:31
09/11/19
09/11
11:31
09/11/19
11:31

Guardant Health should be bought on weakness, says Canaccord

In an earlier research note to investors, Canaccord analyst Mark Massaro reiterated a Buy rating and $125 price on Guardant Health shares, and noted that he met with Guardant Health co-founder and CEO Helmy Eltoukhy and CFO Derek Bertocci. The analyst says the CEO touted innovation, risk-taking, and TAM expansion, and indicated that the analyst's $120B global TAM estimate for Guardant is "not far off." Further, as the company launches new franchises, it sees geometric increases in available market size, and overlapping growth cycles for many years to come, the analyst adds. Despite some recent weakness in shares, Massaro would be a buyer on the dip.

  • 24

    Sep

  • 27

    Sep

GH Guardant Health
$76.00

-4.86 (-6.01%)

04/16/19
ADAM
04/16/19
INITIATION
Target $90
ADAM
Buy
Guardant Health initiated with a Buy at Canaccord
Canaccord analyst Mark Massaro initiated Guardant Health with a Buy rating and $90 price target, saying the company is accelerating its mission to conquer cancer globally and views Guardant as the leader in liquid biopsy cancer testing. Guardant expects to submit G360 to the FDA for break-through device approval by mid-2019 and expects FDA approval by the end of 2019 or early 2020, which he thinks will reduce push back from the remaining 40% of U.S.-based oncologists who have not yet ordered.
05/10/19
JPMS
05/10/19
NO CHANGE
Target $90
JPMS
Overweight
Guardant Health price target raised to $90 from $85 at JPMorgan
JPMorgan analyst Tycho Peterson raised his price target for Guardant Health to $90 from $85 saying the company last night reported "strong" Q1 results. Th analyst continues to view Guardant as a "best-in-class asset in the attractive liquid biopsy space." He sees upside from current share levels and keeps an Overweight rating on the name.
08/07/19
JPMS
08/07/19
NO CHANGE
Target $135
JPMS
Overweight
Guardant Health price target raised to $135 from $90 at JPMorgan
JPMorgan analyst Tycho Peterson raised his price target for Guardant Health to $135 from $90 saying the company last night reported "extremely strong" Q2 results. The quarter saw "robust" clinical testing momentum coupled with upside from biopharma and development services, Peterson tells investors in a research note. He continues to view Guardant as a "best-in-class asset in the attractive liquid biopsy space" and reiterates an Overweight rating on the shares.
08/07/19
ADAM
08/07/19
NO CHANGE
Target $125
ADAM
Buy
Guardant Health price target raised to $125 from $96 at Canaccord
Canaccord analyst Mark Massaro raised his price target on Guardant Health to $125 from $96 following a monster Q2 beat and raise quarter. In addition to its solid revenue growth, gross margins surged. The analyst said he likes the company's long-term strategic thinking, execution, and global vision across cancers in late stage therapy selection, cancer monitoring, and early-stage cancer screening. Massaro reiterated his Buy rating on Guardant Health shares.

TODAY'S FREE FLY STORIES

PMD

Psychemedics

$8.80

-0.125 (-1.40%)

17:28
09/19/19
09/19
17:28
09/19/19
17:28
Hot Stocks
Psychemedics enters new distribution agreement in Brazil »

Psychemedics announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ETSY

Etsy

$59.05

-0.39 (-0.66%)

17:19
09/19/19
09/19
17:19
09/19/19
17:19
Upgrade
RBC upgrades Etsy to Outperform with $68 target amid free shipping push »

RBC Capital analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 24

    Sep

DAL

Delta Air Lines

$58.68

-0.63 (-1.06%)

17:18
09/19/19
09/19
17:18
09/19/19
17:18
Periodicals
Delta Air Lines flight drops 30K feet in seven minutes, NY Post says »

The NY Post's Yaron…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SCVL

Shoe Carnival

$33.03

0.18 (0.55%)

17:08
09/19/19
09/19
17:08
09/19/19
17:08
Hot Stocks
Shoe Carnival appoints CEO Cliff Sifford as vice chairman »

Shoe Carnival announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FQVLF

First Quantum Minerals

$0.00

(0.00%)

17:06
09/19/19
09/19
17:06
09/19/19
17:06
Periodicals
First Quantum Minerals seeing takeover interest, Bloomberg reports »

First Quantum Minerals,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GVP

GSE Systems

$1.75

0.06 (3.55%)

17:05
09/19/19
09/19
17:05
09/19/19
17:05
Syndicate
GSE Systems requests withdrawal of registration statement »

The company is requesting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JWN

Nordstrom

$32.15

-0.46 (-1.41%)

17:01
09/19/19
09/19
17:01
09/19/19
17:01
Hot Stocks
Nordstrom names Kenneth Worzel as new COO »

In a regulatory 8-K…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AOBC

American Outdoor Brands

$6.04

-0.13 (-2.11%)

, RGR

Sturm, Ruger

$42.84

-0.28 (-0.65%)

16:59
09/19/19
09/19
16:59
09/19/19
16:59
Hot Stocks
Gun maker Colt to stop making AR-15s and other long guns for the civilian market »

Gunmaker Colt says it is…

AOBC

American Outdoor Brands

$6.04

-0.13 (-2.11%)

RGR

Sturm, Ruger

$42.84

-0.28 (-0.65%)

VSTO

Vista Outdoor

$6.47

-0.105 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 24

    Sep

ARNC

Arconic

$27.14

-0.17 (-0.62%)

16:55
09/19/19
09/19
16:55
09/19/19
16:55
Hot Stocks
Arconic to sell forgings business in U.K. to Aero Forgings for roughly $62M »

According to a regulatory…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Nov

DOVA

Dova Pharmaceuticals

$16.00

0.5 (3.23%)

, RIGL

Rigel Pharmaceuticals

$1.71

0.015 (0.89%)

16:55
09/19/19
09/19
16:55
09/19/19
16:55
Conference/Events
Wedbush biotech analysts to hold a dinner meeting »

Biotech Analysts…

DOVA

Dova Pharmaceuticals

$16.00

0.5 (3.23%)

RIGL

Rigel Pharmaceuticals

$1.71

0.015 (0.89%)

ARGX

Argenx

$126.44

-0.94 (-0.74%)

MNTA

Momenta

$13.35

-0.14 (-1.04%)

AMGN

Amgen

$195.64

0.67 (0.34%)

NVS

Novartis

$86.39

0.09 (0.10%)

ALNY

Alnylam

$84.68

-0.87 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 19

    Sep

  • 20

    Sep

  • 24

    Sep

  • 25

    Sep

  • 27

    Sep

  • 27

    Sep

  • 02

    Oct

  • 24

    Oct

  • 04

    Feb

BYND

Beyond Meat

$155.04

1.31 (0.85%)

, TSLA

Tesla

$246.51

3.08 (1.27%)

16:48
09/19/19
09/19
16:48
09/19/19
16:48
Hot Stocks
Beyond Meat names Sanjay Shah COO »

Beyond Meat (BYND)…

BYND

Beyond Meat

$155.04

1.31 (0.85%)

TSLA

Tesla

$246.51

3.08 (1.27%)

AMZN

Amazon.com

$1,822.21

4.21 (0.23%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Oct

  • 12

    Nov

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:40
09/19/19
09/19
16:40
09/19/19
16:40
Earnings
SMTC Corp. guides initial FY20 revenue $390M-$410M, two estimate $421.85M »

Guides initial FY20…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CLXT

Calyxt

$6.97

-0.2 (-2.79%)

16:40
09/19/19
09/19
16:40
09/19/19
16:40
Hot Stocks
Calyxt signs seed agreement with Landus Cooperative in Iowa »

Calyxt has added Landus…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:39
09/19/19
09/19
16:39
09/19/19
16:39
Earnings
SMTC Corp to exit China operations, cuts FY19 revenue view to $354M-$362M »

Two estimates $392.79M. …

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

ACRGF

Acreage Holdings

$0.00

(0.00%)

16:36
09/19/19
09/19
16:36
09/19/19
16:36
Initiation
Acreage Holdings initiated  »

Acreage Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SMTX

SMTC Corp.

$2.96

0.16 (5.71%)

16:36
09/19/19
09/19
16:36
09/19/19
16:36
Hot Stocks
Breaking Hot Stocks news story on SMTC Corp. »

SMTC Corp to exit China…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

16:35
09/19/19
09/19
16:35
09/19/19
16:35
General news
Money Supply M2 Weekly Change data reported »

Week of 9/9 Money Supply…

16:35
09/19/19
09/19
16:35
09/19/19
16:35
General news
Fed Balance Sheet Level data reported »

Week of 9/18 Fed Balance…

FSLR

First Solar

$67.09

1.32 (2.01%)

16:35
09/19/19
09/19
16:35
09/19/19
16:35
Hot Stocks
First Solar transitions to leveraging third-party EPC services »

First Solar, Inc.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HEXO

HEXO Corp

$3.94

-0.175 (-4.25%)

16:35
09/19/19
09/19
16:35
09/19/19
16:35
Initiation
HEXO Corp initiated  »

HEXO Corp initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Nov

CURLF

Curaleaf Holdings

$0.00

(0.00%)

16:34
09/19/19
09/19
16:34
09/19/19
16:34
Initiation
Curaleaf Holdings initiated  »

Curaleaf Holdings…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    Nov

CHNR

China Natural Resources

$2.53

0.13 (5.42%)

16:34
09/19/19
09/19
16:34
09/19/19
16:34
Syndicate
Breaking Syndicate news story on China Natural Resources »

China Natural Resources…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KEY

KeyCorp

$18.04

-0.18 (-0.99%)

16:32
09/19/19
09/19
16:32
09/19/19
16:32
Hot Stocks
KeyCorp CEO Beth Mooney to retire »

KeyCorp announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Oct

ASA

ASA Limited

$12.56

0.25 (2.03%)

16:31
09/19/19
09/19
16:31
09/19/19
16:31
Hot Stocks
ASA Limited reports NAV positive 59.4% for 9 months ended August 31 »

ASA Gold and Precious…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

16:30
09/19/19
09/19
16:30
09/19/19
16:30
Options
Preliminary option volume of 20.3M today »

Preliminary option volume…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.